26646 Federal Register / Vol. 65, No. 89 / Monday, May 8, 2000 / Notices

1 15 U.S.C. 78l(d).

2 17 CFR 240.12d2–2(d).

3 15 U.S.C. 78l(b).

4 15 U.S.C. 78l(g).

5 Id.

6 17 CFR 200.30–3(a)(1).

1 15 U.S.C. 78l(d).

2 17 CFR 240.12d2–2(d).

3 15 U.S.C. 78l(b).

4 15 U.S.C. 78m.

General comments regarding the

above information should be directed to

the following persons: (i) Desk Officer

for the Securities and Exchange

Commission, Office of Information and

Regulatory Affairs, Office of

Management and Budget, New

Executive Office Building, Washington,

D.C. 20503; and (ii) Michael E. Bartell,

Associate Executive Director, Office of

Information Technology, Securities and

Exchange Commission, 450 Fifth Street,

N.W., Washington, D.C. 20549.

Comments must be submitted to OMB

within 30 days of this notice.

Dated: May 1, 2000.

Jonathan G. Katz,

Secretary.

[FR Doc. 00–11403 Filed 5–5–00; 8:45 am]

BILLING CODE 8010–01–M

SECURITIES AND EXCHANGE

COMMISSION

Issuer Delisting; Notice of Application

To Withdraw From Listing and

Registration; (Maxim Pharmaceuticals,

Inc., Common Stock, $.001 Par Value,

and Redeemable Common Stock

Purchase Warrants Expiring July 10,

2001) File No. 1–14430

May 2, 2000.

Maxim Pharmaceuticals, Inc.

(‘‘Company’’) has filed an application

with the Securities and Exchange

Commission (‘‘Commission’’), pursuant

to Section 12(d) of the Securities

Exchange Act of 1934 (‘‘Act’’) 1 and Rule

12d2–2(d) thereunder,2 to withdraw the

securities described above (‘‘Securities’’)

from listing and registration on the

American Stock Exchange LLC

(‘‘Amex’’) and under Section 12(b) of

the Act.3

The Company, whose business is

biotechnology, has undertaken to

transfer trading in its Securities from the

Amex to the National Market of the

Nasdaq Stock Market, Inc. (‘‘Nasdaq’’),

which it considers to be the preeminent

marketplace for the securities of

biotechnology companies. The

Company has registered its Securities

pursuant to Section 12(g) of the Act 4 by

filing a Registration Statement on Form

8–A with the Commission on April 26,

2000. The Securities subsequently

became designated for quotation and

began trading on the Nasdaq National

Market, and were simultaneously

suspended from trading on the Amex,

on April 27, 2000. In making the

determination to withdraw its Securities

from listing and registration on the

Amex in conjunction with the

commencement of trading on the

Nasdaq, the Company hopes to avoid

both the costs of maintaining dual

listings and potential fragmentation of

the market for its Securities.

The Company has stated that it has

complied with the Rules of the Amex

governing the withdrawal of its

Securities from listing and registration

on the Exchange, and that the Amex in

turn has indicated that it will not

oppose such withdrawal.

The Company’s application relates

solely to the withdrawal of the

Securities from listing and registration

on the Amex and shall have no effect

upon the Securities’ designation for

quotation and trading on the Nasdaq

National Market and registration under

Section 12(g) of the Act.5

Any interested person may, on or

before May 23, 2000, submit by letter to

the Secretary of the Securities and

Exchange Commission, 450 Fifth Street,

N.W., Washington, D.C. 20549–0609,

facts bearing upon whether the

application has been made in

accordance with the rules of the Amex

and what terms, if any, should be

imposed by the Commission for the

protection of investors. The

Commission, based on the information

submitted to it, will issue an order

granting the application after the date

mentioned above, unless the

Commission determines to order a

hearing on the matter.

For the Commission, by the Division of

Market Regulation, pursuant to delegated

authority.6

Jonathan G. Katz,

Secretary.

[FR Doc. 00–11401 Filed 5–5–00; 8:45 am]

BILLING CODE 8010–01–M

SECURITIES AND EXCHANGE

COMMISSION

Issuer Delisting; Notice of Application

To Withdraw From Listing and

Registrations; (Rogers Corporation,

Capital Stock, $1 Par Value, and Rights

to Purchase Capital Stock, $1 Par

Value) File No. 1–04347

May 2, 2000.

Rogers Corporation (‘‘Company’’) has

filed an application with the Securities

and Exchange Commission

(‘‘Commission’’), pursuant to Section

12(d) of the Securities Exchange Act of

1934 (‘‘Act’’) 1 and Rule 12d2-2(d)

thereunder, 2 to withdraw the securities

to described above (‘‘Securities’’) from

listing and registration on the American

Stock Exchange LLC (‘‘Amex’’).

The Company is seeking to withdraw

its Securities from listing and

registration on the Amex in conjunction

with the commencement of their trading

on the New York Stock Exchange, Inc.

(‘‘NYSE’’). The Company hopes that,

with a NYSE listing, it will be able to

realize a broader market base for its

Securities than it has had through the

Amex.

Subsequent to the filing of the

Company’s Registration Statements on

Form 8–A with the Commission, which

became effective on April 6, 2000,

trading in the Securities commenced on

the NYSE, and was simultaneously

suspended on the Amex, at the opening

if business on April 18, 2000. In making

the determination to withdraw its

Securities from listing and registration

on the Amex in conjunction with the

new listing and registration on the

NYSE, the Company hopes to avoid

both the costs associated with

maintaining dual listings and potential

fragmentation of the market for its

Securities.

The Company has stated that it has

complied with the rules of Amex

governing the withdrawal of its

Securities, and the Amex in turn has

indicated that it will not opposed such

withdrawal.

The Company’s application relates

solely to the withdrawal of the

Securities from listing and registration

on the Amex and shall have no effect no

effect upon the Securities’ continued

listing and registration on the NYSE. By

reason of Section 12(b) of the Act 3 and

the rules and regulations of the

Commission thereunder, the Company

shall continue to be obligated to file

reports with the Commission under

Section 13 of the Act.4

Any interested person may, on or

before May 23, 2000, submit by letter to

the Secretary of the Securities and

Exchange Commission, 450 Fifth Street,

N.W., Washington, D.C. 20549–0609,

facts bearing upon whether the

application has been made in

accordance with the rules of the Amex

and what terms, if any, should be

imposed by the Commission for the

protection of investors. The

Commission, based on the information

submitted to it, will issue an order

granting the application after the date